Drugs / fecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04406129 | Mar 2021 → Feb 2022 | essential hypertension | Chinese Academy of Medical Sciences, Fuwai Hospital | Unknown | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fecal microbiota transplantation | “a novel strategy involving fecal microbiota transplantation (FMT) has been proposed to treat hypertension, but its efficacy has not been investigated in the clinic.” PMID 40410854 ↗ May 2025 |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04406129 ↗ |
| Modality | Other / unclassified | “fecal microbiota transplantation (FMT)” NCT04406129 ↗ |
| Route | Oral | “FMT capsules will be orally taken on Day 1, Day 7 (Week 1) and Day 14 (Week 2).” NCT04406129 ↗ |